startup
Telum Therapeutics raises €18 million to advance treatments for hospital-acquired infections
Source:
eu-startups.com 1 min read
Share
You are reading a summary. The full content is hosted on eu-startups.com.
Telum Therapeutics, a Spanish BioTech company, today announced the successful completion of an €18 million Series A financing to advance its lead programme targeting hospital-acquired (HABP) and ventilator-associated bacterial pneumonia (VABP). AMR Action Fund led the financing round, with participation from new investor Inveready and continued support from existing investors Invivo Partners, CDTI with its […] The post Telum Therapeutics raises €18 million to advance treatments for hospital-acquired infections appeared first on EU-Startups.
Read the full article on the original website
External link to eu-startups.com
Related Articles
startup
Sources: Uber halts plans to launch food delivery in five of the seven European countries it had targeted for expansion as it pursues a Delivery Hero takeover (Kieran Smith/Financial Times)
1 min read •
startup
India issues a notice to Telegram, asking it to curb the spread of pirated films and other copyrighted content, and seeks an action-taken report within 15 days (Sejal Sharma/Hindustan Times)
1 min read •
startup
Trump's God, guns and anticommunist Fourth of July
2 min read •